Middle East and Africa Genetic Testing Market

Middle East and Africa Genetic Testing Market Size (2024 to 2029)

The genetic testing market size in the Middle East & Africa was worth USD 3.92 billion in 2023 and is estimated to reach USD 5.77 billion by 2029 from USD 4.18 billion in 2024, growing at a CAGR of 6.64% during the forecast period.

Genetic testing has been widely used in pharmacogenomics, often known as drug-gene testing. Furthermore, genetic testing methodologies are projected to enhance market growth throughout the forecast period. These test findings can be used to monitor a current health condition, diagnose an undetected medical issue, or provide information on personal health characteristics.

The rise in the prevalence of genetic disorders and cancer has had a favorable impact on the growth of the genetic testing market in the Middle East and Africa. During the forecast period, personalized medicine therapy is expected to boost the market growth. As the demand for quick, cost-effective, and accurate tests grows, several firms consider giving actionable recommendations alongside the test findings. Customers are more likely to seek out customized services due to this technique, which boosts customer satisfaction. In addition, direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests from a lab without going through a healthcare provider. Additionally, factors such as technological advancements in the field of genetic testing, as well as the rising risk of chromosomal abnormalities as maternal age rises, are further estimated to accelerate the growth rate of the market. In addition, the growing incidence of male and female infertility is also forecasted to contribute to the market’s growth.

During the forecast period, however, standardized debates about genetic test-based diagnostics and tight legal requirements for product approvals are projected to hamper the growth of the genetic testing market in the MEA region.

This research report on the genetic testing market in the Middle East and Africa has been segmented and sub-segmented into the following categories.

Middle East and Africa GeneticTesting Market Analysis By Application

• Cancer Testing
• Pharmacogenomics Testing
• Prenatal Testing
• Predisposition Testing

Middle East and Africa GeneticTesting Market Analysis By Test

• Carrier Testing
• Diagnostic Testing
• Prenatal Testing
• Neonatal Testing

Middle East and Africa GeneticTesting Market Analysis By Country

• KSA
• UAE
• Israel
• Rest Of GCC Countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• Rest Of MEA

Geographically, the Middle East and Africa is projected to account for a moderate share of the global genetic testing market during the forecast period. However, the market in this region is forecasted to register a steady growth rate during the forecast period. Due to increased demand for direct-to-consumer genetic testing and rising consumer interest in personalized medications, MEA has a moderate share of worldwide markets. In addition, the genetic testing market in this region is growing due to increased affordability, rising healthcare spending, and increased awareness of genetic illnesses early detection.

Countries such as UAE and Kuwait are increasing their healthcare capital equipment expenditures, the installed base of various types of products for the genetic testing market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios, all of which affect the genetic testing market.

When present in two copies, individuals with a copy of a gene mutation that causes a hereditary ailment is detected through genetic testing in the research. This type of test is accessible to those who have a family history of genetic disorders and people who are at a higher risk of certain genetic illnesses because of their ethnicity. In addition, if both parents are tested, the test can reveal information regarding the risk of a child developing a genetic condition.

The market for genetic testing in the Middle East and Africa is predicted to rise significantly in the future, owing to an increase in the occurrence of genetic illnesses and cancer and a growing population as more excellent knowledge and adoption of personalized therapies.

KEY MARKET PLAYERS

Companies that are playing a significant role in the Middle East and Africa genetic testing market profiled in this report include Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.